The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

SGLT2 Inhibitors in HFpEF Treatment

Efficacy of SGLT2i in heart failure with preserved EF.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Kardiyoloji department. Book Appointment →

What is SGLT2 Inhibitors in HFpEF Treatment?

HFpEF accounts for approximately half of all HF cases.

EMPEROR-Preserved demonstrated that empagliflozin reduces hospitalization in HFpEF.

Symptoms

Exertional dyspnea
Exercise intolerance
Edema
Orthopnea

Risk Factors

Advanced age
Female gender
Hypertension
Obesity
AF

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Worsening symptoms
  • Recurrent hospitalizations

Treatment Methods

01
Empagliflozin 10 mg/day
02
Diuretics
03
HT control
04
AF management
05
Weight management
06
Rehabilitation

Which Department to Visit?

You can visit our Kardiyoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Kardiyoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.